...
首页> 外文期刊>American Journal of Physiology >Kidney injury molecule-1: a tissue and urinary biomarker for nephrotoxicant-induced renal injury.
【24h】

Kidney injury molecule-1: a tissue and urinary biomarker for nephrotoxicant-induced renal injury.

机译:肾损伤分子-1:肾毒性剂引起的肾损伤的组织和尿液生物标志物。

获取原文
获取原文并翻译 | 示例
           

摘要

Nephrotoxicity is a common side effect of therapeutic interventions, environmental insults, and exposure to toxicants in the workplace. Although biomarkers for nephrotoxicity are available, they often lack sensitivity and are not specific as indicators of epithelial cell injury. Kidney injury molecule-1 (Kim-1) is a type 1 membrane protein with extracellular immunoglobulin and mucin domains. The mRNA and protein for Kim-1 are expressed at very low levels in normal rodent kidney, but expression increases dramatically after injury in proximal tubule epithelial cells in postischemic rodent kidney and in humans during ischemic acute renal failure. To evaluate the utility of Kim-1 as a biomarker for other types of renal injury, we analyzed tissue and urinary expression in response to three different types of nephrotoxicants in the rat: S-(1,1,2,2-tetrafluoroethyl)-l-cysteine (TFEC), folic acid, and cisplatin. Marked increases in Kim-1 expression were confirmed by immunoblotting in all three models. The protein was shown to be localized to the proximal tubule epithelial cell by immunofluorescence. Furthermore, Kim-1 protein was detected in urine of toxicant-treated rats. The temporal pattern of expression in response to TFEC is similar to the Kim-1 expression pattern in the postischemic kidney. In folic acid-treated kidneys, Kim-1 is clearly localized to the apical brush border of the well-differentiated proximal tubular epithelial cells. After folic acid treatment, expression of Kim-1 is present in the urine despite no significant increase in serum creatinine. Cisplatin treatment results in early detection of urinary Kim-1 protein and diffuse Kim-1 expression in S3 cells of the proximal tubule. Kim-1 can be detected in the tissue and urine on days 1 and 2 after cisplatin administration, occurring before an increase in serum creatinine. The upregulation of expression of Kim-1 and its presence in the urine in response to exposure to various types of nephrotoxicants suggest that this protein may serve as a general biomarker for tubular injury and repair processes.
机译:肾毒性是治疗干预,环境侮辱和工作场所接触毒物的常见副作用。尽管有用于肾毒性的生物标志物,但它们通常缺乏敏感性,并且不作为上皮细胞损伤的指标。肾损伤分子1(Kim-1)是具有细胞外免疫球蛋白和粘蛋白结构域的1型膜蛋白。在正常啮齿动物肾脏中,Kim-1的mRNA和蛋白的表达水平非常低,但在缺血性啮齿动物肾脏中的近端小管上皮细胞和缺血性急性肾衰竭期间的人中,表达水平显着增加。为了评估Kim-1作为其他类型的肾损伤的生物标记物的效用,我们分析了大鼠中三种不同类型的肾毒物的组织和尿液表达:S-(1,1,2,2-四氟乙基)- l-半胱氨酸(TFEC),叶酸和顺铂。通过免疫印迹在所有三个模型中证实了Kim-1表达的显着增加。通过免疫荧光显示该蛋白定位于近端小管上皮细胞。此外,在用毒物治疗的大鼠的尿液中检测到Kim-1蛋白。响应TFEC的时间表达模式类似于缺血后肾脏中的Kim-1表达模式。在叶酸治疗的肾脏中,Kim-1明显位于分化良好的近端肾小管上皮细胞的顶端刷缘。叶酸治疗后,尽管血清肌酐没有明显增加,但尿液中仍存在Kim-1的表达。顺铂治疗可导致早期发现尿中Kim-1蛋白并在近端小管S3细胞中扩散Kim-1表达。顺铂给药后第1天和第2天,在血清肌酐升高之前,可以在组织和尿液中检测到Kim-1。暴露于各种类型的肾毒性药物后,Kim-1表达的上调及其在尿液中的存在表明该蛋白可作为肾小管损伤和修复过程的一般生物标志物。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号